Skip to main content
logo
Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
0.5416
-0.0187 (-3.34%)
At close: Oct 22, 2026, 4:00 PM EDT
0.54285
+0.0013 (0.24%)
After-hours: Oct 22, 2026, 4:04 PM EDT

Aprea Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.010.291.50.58--
Revenue Growth
-99.38%-80.98%157.63%---
Gross Profit
-6.72-6.76-7.86-7.04-16.4-23.9
Operating Income
-13.22-13.23-14.32-15.47-37.37-37.45
Net Income
-12.31-12.6-12.96-14.29-112.66-37.13
Earnings Per Share
-0.60-1.93-2.35-3.95-67.99-34.88
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
41.2314.622.8521.6128.7953.08
Total Debt
-----0.19
Net Cash (Debt)
41.2314.622.8521.6128.7952.89
Net Cash Growth
149.41%-36.11%5.75%-24.94%-45.57%-
Net Cash Per Share
2.002.234.155.9717.3749.69

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-12.17-12.89-13.56-12.18-25.01-37.69
Capital Expenditures
-0.02--0.02-0.09--
Free Cash Flow
-12.18-12.89-13.57-12.27-25.01-37.69
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Margin
-255025.52%-4631.12%-953.00%-2652.80%--
Pretax Margin
-237362.80%-4409.16%-862.43%-2449.59%--
Profit Margin
-237362.80%-4409.16%-862.43%-2449.59%--
FCF Margin
-234974.18%-4512.35%-903.26%-2103.92%--

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
1315.2120.8811.9030.11--